(Q34181257)

English

Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

M W Saif

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R F Little

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J M Hamilton

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

C J Allegra

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

W H Wilson

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

123-129

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Letter: Subacute and chronic active hepatitis after withdrawal of chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B infection in patients with lymphomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987-1991.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

The development of a mutation in the precore region of the hepatitis B virus in a chronically infected individual

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

C ASE R EPORT: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008350507748

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008350507748

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34181257&oldid=1605952959"